Résultats de la recherche - 2232 results
The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review
This study aims to estimate the impact of the pandemic on delayed CVD care in Europe by providing a systematic overview of the available evidence. METHODS AND RESULTS: PubMed, Embase, and Web of Science ...
A proposal for further developing fatigue-related post COVID-19 health states for burden of disease studies
from the World Health Organization. In practice this means that milder cases, that may be occurring very frequently, are not included in estimates of the burden of long COVID which will result in ...
Comparing frailty prevalence between countries: validation of the Global Burden of Disease study Frailty Index (GBD-FI) in the survey of health, ageing and retirement in Europe
Area under receiver operating characteristic curves (AUC) were fitted to examine diagnostic accuracy for frailty and predictive validity for 2-year mortality. RESULTS: In total, 31,624 participants aged ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
random-effects meta-analysis. RESULTS: For ≥80 years, considering unvaccinated as the reference, VE against COVID-19 hospitalisation decreased from 66.9% (95% CI: 60.1; 72.6) to 36.1% (95% CI:-27.3; 67.9) for the primary ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
country-specific weekly RSV counts of sentinel, non-sentinel and Severe Acute Respiratory Infection (SARI) surveillance specimens and calculated percentage positivity. Results for both 2020/21 and 202½2 seasons and ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
70% (95% CI: 61-77) and 36% (95% CI: 17-51) for those with onset 14-59 days, 60-119 days and 120-179 days after booster vaccination, respectively.ConclusionsOur results suggest that, during the ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
90-179 days before onset.ConclusionsOur results from this EU multi-country hospital setting showed that VE for complete PSV alone was higher in the Alpha- than the Delta-dominant period, and addition of ...
Belgian general practitioners’ perception and use of physical activity on prescription
GP s between January and end of March 2023. The survey has 41 (ordinal or multiple choice) questions. Descriptive statistics were performed. Results 134 GP s completed the survey of which 56% were ...
Dietary exposure of Sorbates (E 200 – 202) and Benzoates (E 210 – 213) for the Belgian population
(EC) No 1333/2008 requires the Member States to monitor the consumption and use of FA s using a risk-based approach and communicate the results to the European Commission and the National authorities. ...
Federated causal inference based on real-world observational data sources: application to a SARS-CoV-2 vaccine effectiveness assessmentAbstractIntroductionMethodsResultsConclusions
individuals based on confounders identified in the causal model and a survival analysis within the matched population. Results The conceptual and instrumental phase of the proposed methodological framework was ...